Ardelyx (ARDX) Announces 9:4 FDA Vote AdCom Vote Favoring XPHOZAH
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- S&P 500, Dow rise as AI boost counters US-Iran tensions
- Oil rises, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
Ardelyx (ARDX) Director Mott Buys $1M in Stock Following Positive FDA Panel
November 17, 2022 4:14 PM ESTArdelyx (NASDAQ: ARDX) Director, David Mott, bought 567,000 shares on 11/17/22 at $1.7648.
The value of the purchase was just over $1 million and follows a positive FDA panel vote.
... MoreArdelyx, Inc (ARDX) Stock 'Acting Poorly' Despite 50% Up Move - Citi
November 17, 2022 1:01 PM ESTCiti analyst Yigal Nochomovitz reiterated a Buy rating and $10.00 price target on Ardelyx, Inc (NASDAQ: ARDX), saying with the stock up less than 50% it is acting poorly (only up... More
